Jennifer Brandl is the Associate Director of Clinical Operations at Kezar Life Sciences. She has 15 years of experience as a researcher and clinical operations specialist, and she is currently pursuing a Master’s degree in Data Science from the University of Wisconsin.
Jennifer credits her prior experience at a smaller biotech company with giving her a critical foundation in clinical conduct and study execution. At Kezar, she leverages this expertise and her passion for research to support the company’s development of pioneering therapies and to change the lives of patients.
Episode Highlights
The elements of Jennifer’s expertise that have especially helped her drive success in the trials she manages
The benefits of functional service provider outsourcing models
How Kezar’s patient-centric nature had the company well prepared to navigate the COVID-19 pandemic
The greatest challenges Jennifer and Kezar experienced due to the pandemic, and some positive outcomes
Important considerations for organizations exploring home health options
How communication and relationship-building form the foundation of clinical trial work
The challenges and benefits she’s experienced conducting site initiation visits virtually
How best to prepare before updating or transforming site initiation processes
What she believes is next for decentralized clinical trials
How automation and tech adoption can help extract more insight from data
Podden och tillhörande omslagsbild på den här sidan tillhör
ArcheMedx Inc.. Innehållet i podden är skapat av ArcheMedx Inc. och inte av,
eller tillsammans med, Poddtoppen.
